ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Synonyms: CD87; Monocyte activation antigen Mo3; U-PAR; Urokinase plasminogen activator surface receptor
Storage: 2-8C
Application: Inhibits Activity/Function: A representative lot of this antibody inhibited the invasion of MDA-MB-231 cells (Harel, E., et al., 2014 UCSF Scientific Poster).Flow Cytometry Analysis: 0.1 mug from a representative lot detected uPAR in one million SH-SY5Y cells.Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected uPAR in human lung cancer tissue sections.Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected uPAR in HT1080 cells.Note: Actual optimal working dilutions must be determined by the end user as specimens and experimental conditions may vary.
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany